Study | Sample Size (n) | Study Drug vs. Control | Results (n) | Major Bleeds (n) | HIT (n) | Deaths (n) |
---|---|---|---|---|---|---|
Dechavanne,1989 [17] | D1 = 42 D2 = 41 H = 41 | D - 2500 IU SC 2 h pre-op, then q 12 h post-op × 10-13 days | DVT (all) D1 - 2 D2 - 3 H - 4 |  | D1 - 0 D2 - 0 H - 0 |  |
 |  | D - 2500 IU SC 2 h pre-op, then q 12 h post-op × 48 h, then 5000 IU q AM × 10-13 days | DVT (proximal) D1 - 1 D2 - 1 H - 3 |  |  |  |
 |  | H - 5000 IU SC 2 h pre-op, then bid × 2 days post-op, then H dosage was adjusted according to aPTT × 10-13 days |  |  |  |  |
Tørholm, 1991 [16] | D = 60 P = 60 | D - 2500 IU SC 2 h pre-op and 12 h post-op, then 5000 IU qAM × 6 days | DVT D - 9 P - 19 |  |  | D - 1 P - 0 |
 |  | P - 2 h pre-op and 12 h post-op, then qAM × 6 days | PE D - 0 P - 1 |  |  |  |
Dahl, 1997 [19] | D = 134 P = 131 | D - 5000 IU SC evening before op and qPM × 7 days, then 5000 IU SC qPM × 28 days (±2 days) | DVT within first 7 days D - 4 P - 3 |  | D - 0 P - 0 | D - 0 P - 0 |
 |  | P - 5000 IU SC evening before op and qPM × 7 days, then placebo × 28 days (±2 days) | DVT within 35 days D - 22 P - 23 |  |  |  |
 |  |  | PE within 35 days D - 0 P - 1 |  |  |  |
Lassen, 1998 [20] | D = 140 P = 141 | D - 5000 IU SC qd, starting 12 h pre-op and × 7 days post-op; then 5000 IU qd × 28 days | DVT (all) D - 5 P - 12 | D - 0 P - 1 | D - 0 P - 1 |  |
 |  | P - 5000 IU SC qd, starting 12 h pre-op and × 7 days post-op; then placebo × 28 days | DVT (proximal) D - 1 P - 5 |  |  |  |
 |  |  | PE D - 0 P - 0 |  |  |  |
Hull, 2000a [21] | D1 = 504 D2 = 494 W = 500 | D1 (pre-op) - 2500 IU SC within 2 h before surgery, then 2500 IUSC 4 or more h after surgery, then 5000 IU SC qAM × 6 days (±2) | DVT (all) D1 - 36 D2 - 44 W - 81 | First 8 days D1 - 44 D2 - 32 W - 22 | D1 - 6 D2 - 4 W - 10 | D1 - 2 D2 - 0 W - 2 |
 |  | D2 (post-op) - Placebo within 2 h before surgery, then 2500 IU SC 4 h or more after surgery, then 5000 IU SC qAM × 6 days (±2) | DVT (proximal) D1 - 3 D2 - 3 W - 11 |  |  |  |
 |  | W - 10 mg PO evening after surgery (5 mg if ≥ 70 years old), then qd dosing by nomogram × 6 days (±2) | PE D1 - 0 D2 - 0 W - 0 |  |  |  |
Hull, 2000b [22] | D1 = 199 D2 = 190 W = 180 | D (pre-op) - 2500 IU SC within 2 h before surgery, then 2500 IU SC 4 or more h after surgery, then 5000 IU qAM in-hospital, then 5000 IU qd up to 35 days (±2) | DVT (all) out of hospital within first 35 days D1 - 8 D2 - 6 P - 14 | Major bleeds out of hospital within first 35 days D1 - 0 D2 - 0 P - 0 | D1 - 0 D2 - 0 P - 0 | D1 - 0 D2 - 0 P - 1 |
 |  | D (post-op) - 2500 IU SC 4 or more h after surgery, then 5000 IU qAM in-hospital; then 5000 IU qd up to 35 days (±2) | DVT (proximal) out of hospital within first 35 days D1 - 2 D2 - 1 P - 7 |  |  |  |
 |  | W - 10 mg PO evening after surgery (5 mg if ≥ 70 years old or < 57 kg), then qd dosing by nomogram in-hospital, then placebo up to 35 days (±2) | PE out of hospital within first 35 days D1 - 0 D2 - 0 P - 0 |  |  |  |
Turpie, 1986 [23] | E = 50 P = 50 | E - 30 mg SC bid, started 12-24 h post-op, then qd × 14 days or until discharge | DVT (all) E - 6 P - 21 | E - 1 P - 2 |  | E - 0 P - 1 |
 |  | P - 30 mg placebo SC bid started 12-24 h post-op, then × 14 days or until discharge | DVT (proximal) E - 2 P - 10 |  |  |  |
 |  |  | PE E - 0 P - 0 |  |  |  |
Planes, 1988 [24] | E = 124 H = 113 | E - 40 mg SC starting 12 h (the day before surgery) pre-op, then qd × 14 days or until discharge | DVT (all) E - 15 H - 27 | E - 2 H - 0 |  | E - 0 H - 0 |
 |  | H - 5000 IU SC starting 2 h (on the day of surgery) pre-op, then tid × 14 days or until discharge | DVT (proximal) E - 9 H - 20 |  |  |  |
 |  |  | PE E - 2 H - 3 |  |  |  |
Levine, 1991 [25] | E = 333 H = 332 | E - 30 mg SC bid, starting 12-24 h post-op, then bid × 14 days or until discharge | DVT (all) E - 57 H - 63 | E - 11 H - 19 | E - 0 H - 2 | E - 0 H - 0 |
 |  | H - 7500 IU SC bid, starting 12-24 h post-op, then bid × 14 days or until discharge | DVT (proximal) E - 16 H - 18 |  |  |  |
 |  |  | PE E - 0 H - 1 |  |  |  |
Colwell, 1994 [26] | E1 = 195 E2 = 205 H = 210 | E1 - 30 mg SC q 12 h × 7 days E2 - 40 mg SC qdx 7 days H - 5000 IU SC q 8 h × 7 days | DVT (all) E1 - 9 E2 - 30 H - 24 | E1 - 8 E2 - 3 H - 13 | E1 - 7 E2 - 3 H - 5 | E1 - 1 E2 - 0 H - 2 |
 |  |  | DVT (proximal) E1 - 4 E2 - 8 H - 10 |  |  |  |
 |  |  | PE E - 0 H - 3 |  |  |  |
Avikainen, 1995 [27] | E = 83 H = 84 | E - 40 mg SC qd, starting 12 h pre-op, then qd × 10 days | DVT (all/proximal) E - 1 H - 4 | E - 7 H - 7 |  |  |
 |  | H - 5000 IU SC bid, starting 2 h pre-op and 12 h post-op, then bid × 10 days | PE E - 0 H - 1 |  |  |  |
Bergqvist,1996 [28] | E = 131 P = 131 | E - 40 mg SC qd starting 12 h pre-opx 7-11 days then 40 mg SC qd post-op × 21 days | DVT (all) E - 21 P - 45 |  | E - 1 P - 0 | E - 0 P - 0 |
 |  | E P - 40 mg SC qd starting 12 h pre-op × 7-11 days then placebo qd post-op up to 21 days | DVT (proximal) E - 8 P - 28 |  |  |  |
 |  |  | PE E - 0 P - 2 |  |  |  |
Planes, 1996 [29] | E = 90 P = 89 | E - 40 mg SC qd × 21 days P - qd × 21 days | DVT (all) E - 6 P - 17 | E - 0 P - 0 | E - 0 P - 0 | E - 0 P - 0 |
 |  |  | DVT (proximal) E - 5 P - 7 |  |  |  |
 |  |  | PE E - 0 P - 0 |  |  |  |
Rader, 1998 [30] | E = 70 H = 56 | E - 5000 IU SC PM pre-op and AM and PM op day, then post-op enoxaprin 40 mg SC qd × 13-21 days | DVT (all) E - 2 H - 1 | E - 0 H - 0 |  |  |
 |  | H - 5000 IU SC PM pre-op and AM and PM op day, then 5000 IU SC tid × 3 days, then 7500 IU tid on 4th day post-op × 13-21 days | PE E - 0 H - 0 |  |  |  |
Comp, 2001 [31] | E = 224 P = 211 | E - 30 mg SC bid, starting 12-24 h post-op and continuing 7-10 days; then enoxaparin 40 mg SC qd × 18-21 days | DVT (all) E - 18 P - 49 | E - 0 P - 0 | E - 3 P - 2 |  |
 |  | P - enoxaparin 30 mg SC bid, starting 12-24 h post-op and continuing 7-10 days; then placebo qd × 18-21 days | DVT (proximal) E - 6 P - 27 |  |  |  |
 |  |  | PE E - 0 P - 1 |  |  |  |
Senaran, 2006 [32] | E = 50 H = 50 | E - 40 mg SC qd, starting 12 h pre-op × 7-10 days until discharge | DVT during hospitalization (first 7-10 days) E - 0 H - 2 | E - 2 H - 0 | E - 0 H - 0 | E - 0 H - 0 |
 |  | H - 5000 IU SC, starting q 8 h pre-op, then continued to 15,000 IU qd in 3 equal doses q 8 h × 7-10 days until discharge | DVT within 45 days after discharge E - 2 H - 0 |  |  |  |
 |  | * 45 day post discharge follow up | PE E - 0 H - 0 |  |  |  |
Fuji, 2008 [33] | E1 = 104 E2 = 105 E3 = 107 P = 105 | E1 - 20 mg SC qd, started 24-26 h post-op, then qd × 14 days | DVT (all) E1 - 21 E2 - 18 E3 - 27 P - 36 | E1 - 1 E2 - 3 E3 - 2 P - 0 |  |  |
 |  | E2 - 20 mg SC bid, started 24-26 h post-op then qd × 14 days |  |  |  |  |
 |  | E3 - 40 mg SC qd, started 24-26 h post-op, then qd × 14 days | DVT (proximal) E1 - 3 E2 - 3 E3 - 6 P - 9 |  |  |  |
 |  | P - qd × 14 days |  |  |  |  |
 |  | *Follow-up at 90 days after surgery | PE E1 - 0 E2 - 0 E3 - 0 P - 0 |  |  |  |